ロード中...
ACE2 inhibits breast cancer angiogenesis via suppressing the VEGFa/VEGFR2/ERK pathway
BACKGROUND: Breast cancer angiogenesis is key for metastasis and predicts a poor prognosis. Angiotensin-converting enzyme 2 (ACE2), as a member of the renin-angiotensin system (RAS), was reported to restrain the progression of hepatocellular carcinoma (HCC) and non-small cell lung cancer (NSCLC) thr...
保存先:
| 出版年: | J Exp Clin Cancer Res |
|---|---|
| 主要な著者: | , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BioMed Central
2019
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6482513/ https://ncbi.nlm.nih.gov/pubmed/31023337 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13046-019-1156-5 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|